October 3, 2024

US Liquid Biopsy Market Size To Cross USD 1,816.95 Mn By 2032

The US liquid biopsy market size accounted for US$ 362.82 Mn in 2022 and is projected to reach around USD 1,816.95 Mn by 2032, growing at a CAGR of 17.48% from 2023 to 2032.

US Liquid Biopsy Market Size 2023 To 2032

Report Summary

The global US liquid biopsy market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the US liquid biopsy market across the globe.

A comprehensive estimate on the US liquid biopsy market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of US liquid biopsy during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2474

US Liquid Biopsy Market Report Scope 

Report CoverageDetails
Market Size in 2022USD 362.82 Million
Market Size by 2032USD 1,816.95 Million
Growth Rate from 2023 to 2032CAGR of 17.48%
Base Year2022
Forecast Period2023 to 2032
Segments CoveredBy Biomarker Types, By Application, By Sample, By End User

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized US liquid biopsy market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Tissue Diagnostics Market Size To Cross USD 122.74 Bn By 2032

US Liquid Biopsy Market Players

The report includes the profiles of key US liquid biopsy market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area

  • ANGLE plc, Biocept Inc.
  • Bio-Rad Laboratories Inc.
  • Epigenomics AG
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche AG
  • Guardant Health Inc.
  • Illumina Inc.
  • MDxHealth SA
  • Menarini Silicon Biosystems
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.

Market Segmentation

By Biomarker Types 

  • Circulating Tumor Cells (CTCs)
  • Circulating Tumor DNA (CTDNA)
  • Extracellular vesicles (EVS)
  • Other Biomarkers

By Application 

  • Cancer Therapeutic Application
  • Reproductive Health
  • Other Therapeutic Application

By Sample 

  • Blood Sample
  • Urine Sample
  • Other

By End User 

  • Hospitals and Laboratories
  • Academic and Research Centers
  • Other End Users

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on US Liquid Biopsy Market 

5.1. COVID-19 Landscape: US Liquid Biopsy Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. US Liquid Biopsy Market, By Biomarker Types

8.1. US Liquid Biopsy Market, by Biomarker Types, 2023-2032

8.1.1. Circulating Tumor Cells (CTCs)

8.1.1.1. Market Revenue and Forecast (2023-2032)

8.1.2. Circulating Tumor DNA (CTDNA)

8.1.2.1. Market Revenue and Forecast (2023-2032)

8.1.3. Extracellular vesicles (EVS)

8.1.3.1. Market Revenue and Forecast (2023-2032)

8.1.4. Other Biomarkers

8.1.4.1. Market Revenue and Forecast (2023-2032)

Chapter 9. US Liquid Biopsy Market, By Application

9.1. US Liquid Biopsy Market, by Application, 2023-2032

9.1.1. Cancer Therapeutic Application

9.1.1.1. Market Revenue and Forecast (2023-2032)

9.1.2. Reproductive Health

9.1.2.1. Market Revenue and Forecast (2023-2032)

9.1.3. Other Therapeutic Application

9.1.3.1. Market Revenue and Forecast (2023-2032)

Chapter 10. US Liquid Biopsy Market, By Sample 

10.1. US Liquid Biopsy Market, by Sample, 2023-2032

10.1.1. Blood Sample

10.1.1.1. Market Revenue and Forecast (2023-2032)

10.1.2. Urine Sample

10.1.2.1. Market Revenue and Forecast (2023-2032)

10.1.3. Other

10.1.3.1. Market Revenue and Forecast (2023-2032)

Chapter 11. US Liquid Biopsy Market, By End User 

11.1. US Liquid Biopsy Market, by End User, 2023-2032

11.1.1. Hospitals and Laboratories

11.1.1.1. Market Revenue and Forecast (2023-2032)

11.1.2. Academic and Research Centers

11.1.2.1. Market Revenue and Forecast (2023-2032)

11.1.3. Other End Users

11.1.3.1. Market Revenue and Forecast (2023-2032)

Chapter 12. US Liquid Biopsy Market, Regional Estimates and Trend Forecast

12.1. U.S.

12.1.1. Market Revenue and Forecast, by Biomarker Types (2023-2032)

12.1.2. Market Revenue and Forecast, by Application (2023-2032)

12.1.3. Market Revenue and Forecast, by Sample (2023-2032)

12.1.4. Market Revenue and Forecast, by End User (2023-2032)

Chapter 13. Company Profiles

13.1. ANGLE plc, Biocept Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Bio-Rad Laboratories Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Epigenomics AG

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Exact Sciences Corporation

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. F. Hoffmann-La Roche AG

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Guardant Health Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Illumina Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. MDxHealth SA

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Menarini Silicon Biosystems

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. QIAGEN N.V.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com